The one you bought.
$3,197
Gain captured
+32.0%Share price
- At publication
- 2.94
- Note's target
- 4.30
- Later price
- 3.88
The note put a 4.30 target on a 2.94 share and showed the fleet economics behind it. You took the position.
Agentic-AI Equity Research
Wall Street Grade. Objective Price Targets.
Give it a ticker. You get back the research that would take weeks.
What you get back
Specimen
Alliance Aviation Services (AQZ.AX)
Initiation · 7 Sep 2026
Price (5 Sep)A$2.94
Target PriceA$4.30
Implied return+46.3%
52-Week Range2.41 – 3.62
Market CapA$0.47B
Enterprise ValueA$1.06B
Prepared byYour name, your firm
Published under your own
branding — every source linked
Published under your own
branding — every source linked
Figure 1 — AQZ.AX Stock Price Performance
Source: Company data, pipeline estimates. Rebased to 100.
■Contracted wet-lease book underwrites 78% of FY27E revenue. Alliance's fleet is committed to Qantas and Virgin under multi-year agreements that reprice with fuel, insulating margin from spot aviation demand. We model 11.4% revenue CAGR to FY29E against consensus 8.1%, driven by E190 deliveries already on the balance sheet.
■Fleet capex peaked in FY25; free cash flow inflects from FY27E. With 70 E190s acquired and the heavy maintenance cycle behind it, we expect capex to fall to A$95M by FY28E vs. A$243M at peak, taking the business to A$180M of cumulative FCF over the forecast period.
■Trades at 4.1x EV/EBITDA vs. 6.8x for regional aviation peers. The discount reflects leverage that our model shows falling to 1.6x net debt/EBITDA by FY28E. Our A$4.30 target blends DCF (A$4.62), comps (A$3.98) and precedents (A$4.21).
| Year to Jun (A$M) | FY24A | FY25A | FY26A | FY27E | FY28E |
|---|---|---|---|---|---|
| Revenue | 590 | 656 | 712 | 794 | 881 |
| Revenue Growth (%) | 18.4% | 11.2% | 8.5% | 11.5% | 11.0% |
| EBITDA | 168 | 191 | 214 | 248 | 281 |
| EBITDA Margin (%) | 28.5% | 29.1% | 30.1% | 31.2% | 31.9% |
| EPS (A$) | 0.21 | 0.24 | 0.28 | 0.36 | 0.44 |
| EV/EBITDA (x) | 6.3x | 5.5x | 5.0x | 4.3x | 3.8x |
A full equity research report of 40–50 pages, built on a live .xlsx model that ships with the client-ready licence.
How it works
An agent that works like an analyst, and checks like an auditor.
You give it a ticker. It does the week.
- Works like an analyst would. Reads all filings, models the numbers, argues the valuation, writes the research.
- Every step is reviewed. A separate agent that never saw the work being done, reviews all the work and ensures all information is accurate.
- Everything can be traced back. Every filing, transcript, and disclosure. All facts have their sources cited.
Nothing here is taken on trust. Multiple subagents review each other and ensure all information is accurate.
Watch it work on a company you know.
Enter a company, or press Run to try Apple.
Researching the company
- Finding the filings
- Reading earnings calls
- Researching competitors and industry
None of which makes the agent infallible. It can misread a filing or carry an error forward, and Analyst Report has not had a registered analyst review the result, which is exactly why every figure stays traceable to its source and why the model behind it ships with live formulas on a client-ready note. Check the work, and make your own investment decisions. The research is not investment advice and for informational purposes only.
What it's worth
Clarity before you invest.
A clear valuation helps you decide what to buy and what to pass on.
SampleIllustrative cases, not a live track record
Based on a $10,000 positionThe one you passed on.
$1,381
Loss avoided
-13.8%Share price
- At publication
- 26.80
- Note's target
- 21.00
- Later price
- 23.10
The note put a 21.00 target on a 26.80 share and showed the contract roll-offs behind it. You stayed out.
Worked examples, not published calls. No real company is named. Price moves are measured from the close at publication; cash figures assume a $10,000 position and exclude dealing costs. Not investment advice.
Why this exists
A note from the founder
Beating the market is hard, but I just made it easier for myself.
I am a private investor looking for an edge in the markets. To do so, I am turning over a lot of rocks. And I really mean a lot. I am looking at the most obscure opportunities.
Oftentimes, however, these are just duds. After hours of research, many of them would just end up on my watchlist.
Now things changed. My agents do the heavy lifting for me. I will then just read the Analyst Report report, and decide if the opportunity justifies more of my time.
Generating alpha just became easier.
Pricing
Research one company. Or your whole list.
Buy reports as you need them, with savings on larger packs. Add monthly coverage for the companies you keep following.
Bulk rates apply at 5 and 10 reports. For 25 or more, request a custom quote.
Personal
For your own investment decisions.
$29
one-time · 1 report
$29 per report
- Detailed research report
- 3-page write-up, exhibits and charts
- Private use only
- Excel model and pitch deck not included
Client-ready
Research you can publish under your name.
$199
one-time · 1 report
$199 per report
- Everything in Personal, licensed to share
- Full Excel model with live formulas
- Your logo and byline on the cover
- Pitch deck included with every report
- Share with clients and subscribers
Choose companies when you use your reports. Packs are valid for 12 months from purchase. No subscription or automatic renewal.
Bulk rates apply as you add companies. Each company includes one rerun per billing month.
Client-ready research, kept current
Monthly coverage
Start with a full report on each company. From the following month, refresh the analysis when you choose.
- One user-triggered rerun per company per billing month
- Research report, Excel model and pitch deck
- Your logo and byline; licensed to share
- The same features at every company count
1 company under coverage
$129/month
$129 per company per month
Initial reports · one-time$199
$199 per report. Monthly billing begins one month after your initial reports are delivered.
Cancel before your next monthly renewal.
Refreshes start with your first monthly billing period. They are not automatic, and unused reruns do not roll over. Adding a new company requires a new initial report.
Planned pricing in USD. Request early access to get started. Checkout and subscriptions are not live; creating an account does not purchase a plan.
Need custom branding or sponsored research?Talk to us ↗
A run that halts is never billed. A note that arrives and is not usable gets re-run, or refunded — your call.
Questions
The things people ask before they buy.
Is this just ChatGPT with a long prompt?
No. A run is five separate pieces of work, each graded against the files it produced by a reviewer with no memory of producing them — a word count read from the document, a balance sheet tested year by year, charts counted by listing the directory. A prompt gives you an answer. This gives you an answer plus the working, and stops when the working does not hold up.
Can I really publish it under my own name?
From the client-ready licence up, yes. The PDF, the model and the exhibits are yours to edit, rebrand and republish — to clients, to subscribers, or into your own note, with no Analyst Report logo on the deliverables and no attribution requirement. A Personal note is the same research, watermarked and meant for your own desk rather than for sending on.
What if a number is wrong?
You will be able to find it. Every claim traces to the filing, transcript or disclosure it came from, and every figure in the note traces to a cell in the model behind it. On a client-ready note that model ships with the report, which is the point of sending a spreadsheet rather than a PDF of one: you can check the number, change the assumption behind it, and watch the valuation move.
Which markets do you cover?
Anything with a public listing and public filings — US, UK, EU, ASX, TSX and most of the smaller exchanges. Coverage is limited by disclosure, not by geography: if the company files and reports, a run can be done on it.
How long does a run take?
About five hours, and it needs nothing from you once it starts. You get an email when the PDF lands.
What happens if the run fails?
It halts and tells you which step it stopped at, rather than filling the gap with something plausible. You keep the steps that finished and the files they produced, and a halted run is not billed. If a note arrives complete but is not usable, we re-run it or refund it — your call.
Is this investment advice?
No. It is research: an argument with its evidence attached, including the bear case argued at full strength. What you do with it is your decision and your responsibility, exactly as it would be with a sell-side note.
Can the agent get it wrong?
Yes. It reads filings the way software reads them, and software misreads things — a restated segment, an unusual accounting treatment, a footnote that changes what a number means. The checks between steps catch a great deal and are the reason a run halts rather than guesses, but they are not a guarantee of correctness, and no output here has been reviewed by a registered analyst. That is precisely why every figure links to its source, and why the model behind it ships with live formulas on a client-ready note: so you can check the work rather than take it on faith. The investment decision, and the responsibility for it, stay yours.
Do I get the spreadsheet, or just the report?
The spreadsheet comes with a client-ready note and with every note on a coverage plan. It has live formulas rather than pasted values — three linked statements, the working capital and debt schedules, and the valuation built on top of them — so you can change a driver and watch the valuation move. A Personal note is the report, the write-up and the exhibits, all at 300 DPI and yours to drop into your own deck; the model it was built on is what the client-ready licence adds.
Every figure
traced to its filing
The model
live formulas, from client-ready up
Your branding
on every client-ready note
Start with the one you keep meaning to look at.
One name, researched properly, in about five hours — and nothing for you to do while it runs.
📈 Research a ticker$29See what a full note contains →